Atmosphere, Gas & Pressure
Carbon-Dioxide Enclosure Modulation Insufficient evidence / under studyD grade Plausibility · Plausible substrate (CO2 has real vascular effects); isolated evidence for the enclosure step is absentAtmosphere, Gas & Pressure Route ambientInvasiveness non-invasiveDirection additive
Modulated CO2 delivered only as one step of a chamber sequence; no isolated evidence for the CO2 step was located.
Origin & lineage
Multi-step chamber sequences (e.g. HOCATT).
Claimed mechanism
Elevated ambient CO2 is claimed to drive vasodilation / oxygen delivery within a chamber protocol.
Plausibility
Plausible substrate (CO2 has real vascular effects); isolated evidence for the enclosure step is absent.
Evidence — grade D
Delivered only as one step of a chamber sequence; no isolated evidence located for the CO2 modulation itself.
Market
Makers: HOCATT and similar.Models: Multi-modal chambers.Price: Clinic.
Kernel — keep vs set aside Keep — real substrate
CO2 has real vascular physiology.
Set aside — claim
No isolated evidence; the step cannot be evaluated apart from the chamber sequence.
Regulatory status by jurisdiction Registration or clearance is a market-access fact, never proof of efficacy.
US — FDA — EU — MDR — Russia — China — NMPA — Australia — TGA —
Sources
This is an evidence atlas — a map, not a marketplace and not medical advice. It reports the mechanism, evidence grade, and regulatory status of the modalities it catalogues, including the views and claims of third parties, with sources cited where they exist. Regulatory registration or clearance is a market-access fact, never proof of efficacy. Nothing here is an endorsement, a diagnosis, or a treatment recommendation. Consult a qualified clinician before making any health decision.
Evidence grades reflect the position of scientific consensus on the available evidence and may change. All trademarks belong to their respective owners; cited material remains the property of its authors.
© 2024–2026 devices.longevity.one